BlackRock’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

BlackRock’s Portfolio CTV.WS Stock Details CTV.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-122,449	Closed	-$11K	–	5557
2024 Q4	$11K	Hold	122,449	–	–	﹤0.01%	5165
2024 Q3	$4.92K	Hold	122,449	–	–	﹤0.01%	5042
2024 Q2	$5.23K	Hold	122,449	–	–	﹤0.01%	5119
2024 Q1	$5.51K	Sell	122,449 -1,300	-1%	-$55	﹤0.01%	5129
2023 Q4	$3.71K	Hold	123,749	–	–	﹤0.01%	5208
2023 Q3	$7.12K	Hold	123,749	–	–	﹤0.01%	5223
2023 Q2	$10.2K	Hold	123,749	–	–	﹤0.01%	5254
2023 Q1	$10.5K	Hold	123,749	–	–	﹤0.01%	5322
2022 Q4	$43.3K	Hold	123,749	–	–	﹤0.01%	5259
2022 Q3	$58K	Hold	123,749	–	–	﹤0.01%	5328
2022 Q2	$20K	Hold	123,749	–	–	﹤0.01%	5557
2022 Q1	$113K	Sell	123,749 -2,176	-2%	-$1.94K	﹤0.01%	5261
2021 Q4	$128K	Buy	+125,925	New	+$157K	﹤0.01%	5208

Other funds holding CTV.WS

Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

BlackRock's CTV.WS Position: Q1 2025 in Review

BlackRock sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q1 2025, closing a stake of 122,449 shares — an estimated $11K sold.

BlackRock first reported a position in CTV.WS in Q4 2021 and held it in 13 quarters. The position peaked at $128K in Q4 2021. 1 fund tracked by Wall St. Rank holds CTV.WS as of Q1 2025.

BlackRock reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q1 2025 after selling out during the quarter.
BlackRock sold 122,449 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q1 2025, an estimated $11K.
BlackRock first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 13 quarters.
BlackRock's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $128K in Q4 2021.
1 fund tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q1 2025.

Based on BlackRock's 13F filing for Q1 2025, filed 2 May 2025.